Randomized trial of a low-molecular-weight heparin (Kabi 2165) versus adjusted-dose subcutaneous standard heparin in the prophylaxis of deep-vein thrombosis after elective hip surgery.

Dechavanne, M; Ville, D; Berruyer, M; Trepo, F; Dalery, F; Clermont, N; Lerat, J L; Moyen, B; Fischer, L P; Kher, A

Dechavanne, M; Ville, D; Berruyer, M; Trepo, F; Dalery, F; Clermont, N; Lerat, J L; Moyen, B; Fischer, L P; Kher, A.

Affiliation

Dechavanne M; Laboratoires d'Hémostase et de Médecine nucléaire, Hôpital E. Herriot, Lyon, France.

Haemostasis ; 19(1): 5-12, 1989.

Article in En | MEDLINE | ID: mdl-2537787

Subject(s)

Heparin, Low-Molecular-Weight/therapeutic use; Heparin/therapeutic use; Hip Prosthesis/adverse effects; Postoperative Complications/prevention & control; Thrombophlebitis/prevention & control; Drug Evaluation; Fibrinogen; Humans; Injections, Subcutaneous; Phlebography; Radionuclide Imaging; Random Allocation; Thrombophlebitis/diagnostic imaging

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Postoperative Complications / Thrombophlebitis / Heparin / Heparin, Low-Molecular-Weight / Hip Prosthesis Type of study: Clinical_trials Limits: Humans Language: En Journal: Haemostasis Year: 1989 Document type: Article Affiliation country: France Country of publication: Switzerland

Search on Google

Add to My VHL

XML

PubMed Links